17 results
8-K
EX-99.2
XLO
Xilio Therapeutics Inc
14 Aug 23
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
7:40am
mXTX301 Day 4 Day 7 Day 4 Day 7 -2 -1 0 1 2 Gene mXTX301 induced specific T cell recruitment into the tumor with minimal peripheral effects mXTX301
8-K
EX-99.1
ssvj2
25 May 23
Regulation FD Disclosure
5:05pm
10-K
1xp4 r7i3
1 Mar 22
Annual report
4:07pm
10-Q
42yrh5h d8d7yum4jzc
2 Dec 21
Quarterly report
4:15pm
424B4
crhtd91izz42ceub09o
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
j7cg 9sylowl
18 Oct 21
IPO registration (amended)
6:04am
S-1
gqq1df wlqp
1 Oct 21
IPO registration
4:49pm
DRS/A
q10qc1gl5 kiv
14 Sep 21
Draft registration statement (amended)
12:00am
DRS
h53klghh
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next